Nuveen Asset Management LLC Has $1.09 Billion Stock Position in Anthem, Inc. (NYSE:ANTM)

Nuveen Asset Management LLC lowered its position in Anthem, Inc. (NYSE:ANTMGet Rating) by 5.3% during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,348,630 shares of the company’s stock after selling 132,059 shares during the quarter. Nuveen Asset Management LLC owned approximately 0.97% of Anthem worth $1,088,683,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently modified their holdings of ANTM. Industrial Alliance Investment Management Inc. purchased a new position in Anthem in the fourth quarter valued at about $26,000. Trust Co. of Vermont bought a new stake in shares of Anthem during the 4th quarter worth about $31,000. Bell Investment Advisors Inc bought a new stake in shares of Anthem during the 3rd quarter worth about $37,000. Fieldpoint Private Securities LLC boosted its stake in shares of Anthem by 57.8% during the 3rd quarter. Fieldpoint Private Securities LLC now owns 101 shares of the company’s stock worth $38,000 after acquiring an additional 37 shares in the last quarter. Finally, Benjamin Edwards Inc. boosted its stake in shares of Anthem by 145.9% during the 4th quarter. Benjamin Edwards Inc. now owns 91 shares of the company’s stock worth $42,000 after acquiring an additional 54 shares in the last quarter. Hedge funds and other institutional investors own 84.28% of the company’s stock.

ANTM traded up $7.65 during trading on Thursday, reaching $512.43. 987,931 shares of the stock traded hands, compared to its average volume of 1,193,833. The company has a quick ratio of 1.36, a current ratio of 1.36 and a debt-to-equity ratio of 0.55. The stock has a market capitalization of $123.54 billion, a PE ratio of 20.17, a P/E/G ratio of 1.35 and a beta of 0.97. The stock’s 50-day moving average is $498.07 and its 200 day moving average is $462.51. Anthem, Inc. has a 12 month low of $355.43 and a 12 month high of $533.68.

Anthem (NYSE:ANTMGet Rating) last issued its quarterly earnings results on Wednesday, April 20th. The company reported $8.25 EPS for the quarter, beating analysts’ consensus estimates of $7.81 by $0.44. The business had revenue of $38.10 billion for the quarter, compared to analysts’ expectations of $37.28 billion. Anthem had a net margin of 4.33% and a return on equity of 18.71%. The business’s quarterly revenue was up 17.6% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $7.01 earnings per share. As a group, equities research analysts anticipate that Anthem, Inc. will post 28.55 EPS for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Friday, June 24th. Stockholders of record on Friday, June 10th will be given a dividend of $1.28 per share. This represents a $5.12 dividend on an annualized basis and a dividend yield of 1.00%. The ex-dividend date is Thursday, June 9th. This is a boost from Anthem’s previous quarterly dividend of $1.13. Anthem’s dividend payout ratio is 20.16%.

Several analysts recently weighed in on ANTM shares. BMO Capital Markets increased their target price on Anthem from $540.00 to $625.00 and gave the company an “outperform” rating in a research note on Monday, April 25th. Deutsche Bank Aktiengesellschaft increased their target price on Anthem from $453.00 to $574.00 and gave the company a “buy” rating in a research note on Friday, April 22nd. Jefferies Financial Group upped their price target on Anthem from $575.00 to $625.00 in a report on Thursday, April 21st. The Goldman Sachs Group increased their target price on Anthem from $527.00 to $605.00 and gave the stock a “buy” rating in a report on Thursday, April 21st. Finally, Truist Financial increased their target price on Anthem from $590.00 to $610.00 in a report on Thursday, April 21st. Two equities research analysts have rated the stock with a hold rating, nineteen have given a buy rating and one has given a strong buy rating to the company. According to data from MarketBeat.com, Anthem presently has a consensus rating of “Buy” and a consensus target price of $544.95.

In related news, EVP Peter D. Haytaian sold 17,703 shares of the company’s stock in a transaction dated Thursday, March 10th. The shares were sold at an average price of $460.71, for a total value of $8,155,949.13. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CAO Ronald W. Penczek sold 2,423 shares of the company’s stock in a transaction dated Thursday, March 3rd. The stock was sold at an average price of $463.68, for a total transaction of $1,123,496.64. The disclosure for this sale can be found here. Insiders have sold a total of 21,116 shares of company stock worth $9,743,637 in the last three months. Insiders own 0.28% of the company’s stock.

Anthem Profile (Get Rating)

Anthem, Inc, through its subsidiaries, operates as a health benefits company in the United States. It operates through four segments: Commercial & Specialty Business, Government Business, IngenioRx, and Other. The company offers a spectrum of network-based managed care health benefit plans to large and small groups, individuals, Medicaid, and Medicare markets.

Read More

Want to see what other hedge funds are holding ANTM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Anthem, Inc. (NYSE:ANTMGet Rating).

Institutional Ownership by Quarter for Anthem (NYSE:ANTM)

Receive News & Ratings for Anthem Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Anthem and related companies with MarketBeat.com's FREE daily email newsletter.